Serial Serum HER2 Measurements for the Detection of Breast Cancer Recurrence in HER2-Positive Patients

PURPOSE: The measurement of serum human epidermal growth factor receptor 2 (HER2) extracellular domain levels is a well-established method for evaluating whether a metastatic HER2-positive breast cancer patient will respond to HER2-targeted treatment. However, little is known about the value of seru...

Descripción completa

Detalles Bibliográficos
Autores principales: Ha, June-Hyung, Seong, Min-Ki, Kim, Eun-Kyu, Lee, Jin Kyung, Seol, Hyesil, Lee, Ju Young, Byeon, Jangmoo, Sohn, Yeun-Ju, Koh, Jae Soo, Park, In-Chul, Noh, Woo Chul, Kim, Hyun-Ah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Breast Cancer Society 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3988340/
https://www.ncbi.nlm.nih.gov/pubmed/24744795
http://dx.doi.org/10.4048/jbc.2014.17.1.33

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3988340/
https://www.ncbi.nlm.nih.gov/pubmed/24744795
http://dx.doi.org/10.4048/jbc.2014.17.1.33

Ejemplares similares